Today: January 17, 2019, 6:14 am
  
Health

HKBU develops world-first metal-based probes for detection of dopamine receptors, a cancer biomarker

HKBU develops world-first metal-based probes for detection of dopamine receptors, a cancer biomarker
PR-Inside.com: 2018-05-23 11:51:25
Discovery can be potentially developed as a novel early cancer detection technology.


HONG KONG, May 16, 2018 - (ACN Newswire) - A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. The discovery has enhanced the understanding of dopamine receptors in carcinogenesis, and the findings can be potentially developed as a novel early cancer detection technology. The study was published in the inside front cover of Chemical Science, the flagship journal of the Royal Society of Chemistry.


Dopamine is an important neurotransmitter in the central nervous system of the human body and plays important roles in motivation, cognition and motor control. While dopamine receptors have long been implicated in neurodegenerative diseases, such as Parkinson's disease, recent evidence has linked dopamine receptors also with various cancers, including lung, breast and colon cancers. Traditional detection methods for dopamine receptors include the enzyme-linked immunosorbent assay (ELISA). However, such methods suffer from high cost, incompatibility with living systems, and are not suitable for the real-time study of the biological role of dopamine receptors.


The metal-based probes developed by the team are able to selectively bind to dopamine receptors on lung cancer cells, "lighting up" the cells and making them visible to the naked eye. The probes enable the monitoring and tracking of dopamine receptors in living cells in a real-time and in a non-invasive fashion. Moreover, the experiment results demonstrated that the imaging colour intensity was correlates with the expression levels of dopamine receptors on cancer cells. These probes could therefore both help to elucidate the role of dopamine receptors in the pathogenesis of cancers and offer a potential diagnostic tool for the early screening of cancers. Importantly, the metal-based probes avoid the problems of poor photostability and photobleaching that limit conventional fluorescent imaging dyes.


The research project entitled "Cell imaging of dopamine receptor using agonist labeling iridium(III) complex" was led by Dr Edmond Ma of HKBU together with Professor Leung Chung-hang of the Institute of Chinese Medical Sciences, University of Macau. Other collaborators of the project included researchers from the School of Chinese Medicine of HKBU, the City University of Hong Kong, University of Florida, USA, and Hunan University, China.


Dr Ma said, "Early detection is crucial for improving the survival rate of hard-to-treat cancers such as lung cancer, which is associated with dopamine receptor expression. For instance, data from the American Cancer Society shows that patients with early stage non-small cell lung cancer (NSCLC) have a five-year survival rate of about 92%, but this drops to only about 36% when the cancer has progressed to an advanced stage. We therefore believe that these dopamine receptor probes show great promise for the development of molecular diagnostic tools for the early detection of cancer."


Dr Ma added that because the probes could successfully track the internalisation process of dopamine receptors in cells, they also represent powerful tools for studying the role of dopamine receptors in the pathogenesis of cancer.


Media enquiries:

Tina Ng of the Communication and Public Relations Office (+852 3411 5262) or Dr Edmond Ma of the Department of Chemistry (+852 3411 7075)


Topic: Press release summary

Sectors: Chemicals, Nanotechnology, BioTech, HealthCare

www.acnnewswire.com

From the Asia Corporate News Network


Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Press Information


Published by
ACN Newswire
+65 6304 8926
e-mail
www.acnnewswire.com



# 567 Words
Related Articles
More From The Author
Central Crypto and Huobi Launch Huobi School [..]
A New Initiative in Quantitative Crypto-trading HONG KONG, May 22, 2018 - (ACN Newswire) - As the digital assets becoming [..]
Coinsuper Initiated the Establishment of Crypto Exchange [..]
- To Connect the Financial World HONG KONG, May 21, 2018 - (ACN Newswire) - Coinsuper, the professional digital asset [..]
AnApp announces the birth of an innovative [..]
HONG KONG, May 21, 2018 - (ACN Newswire) - AnApp Blockchain Technologies Limited ("AnApp") announces the development of [..]
HKTDC Entrepreneur Day 2018 Opens
Most International and Tech-focused Edition Ever HONG KONG, May 17, 2018 - (ACN Newswire) - A record 276 exhibitors are [..]
Novotech: Federal R&D Tax Support Keeps Australia [..]
SYDNEY, AUS, May 18, 2018 - (ACN Newswire) - Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget [..]
 
More From Health
Gamma Knife Surgery in India offer high [..]
India offers high Quality and affordable treatment at affordable cost including the Low-cost Gamma knife surgery India. There [..]
Spine and Neuro Surgery Hospital India planning [..]
16-01-2019, Chennai: The requirement of appropriate Spine and Neuro Surgery treatment is very high all over the globe. Spine and [..]
Medical Tourists Flocking To India for Low [..]
10 DEC 2018: Also known as Renal Cancer, Kidney Cancer is a very prevalent form of Cancer and there are [..]
Diabetes Therapy Program Target Market Is Growing [..]
The Study record offers a total analysis of the marketplace as well as has a future pattern, present development elements, [..]
Cosmetic and Obesity Surgery Hospital providing extensive [..]
Unlike previous days, today Cosmetic surgeries are considered much safer. These surgeries are availed quite frequently these days [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.